Nykode Company
Nykode Therapeutics is a clinical-stage biopharmaceutical platform that develops novel vaccines against HPV-induced malignacies
Headquarters:
Oslo, Oslo, Norway
Employee Number:
11-50
Industry:
Tumor-Specific Antigens
Total Funding:
36596103
Estimated Revenue:
Less than $1M
Investors Number:
5
Last Funding Date:
2016-12-16
Founded Date:
2007-01-01
Last Funding Type:
Venture Round
Funding Status:
Venture